Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Lungpacer Medical USA Inc.
Lungpacer Achieves Commercial Milestone as Leading U.S. Hospital Performs First AeroPace® Procedures to Help Patients Liberate from Mechanical Ventilation
December 09, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Medical Announces First Enrollments in STARI Trial of Next-Generation Neurostimulation Therapy
November 04, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
August 14, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
American Journal of Respiratory and Critical Care Medicine Publishes Landmark Data on AeroPace® System's Breakthrough Results in Ventilator Weaning
June 12, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer to Showcase the Potential of Novel Technologies to Improve Lung, Heart, and Brain Health in Ventilated Patients
April 28, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
March 24, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Medical Announces Investigational Device Exemption (IDE) for STARI, Phase 2 Feasibility Clinical Trial
March 10, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Medical Announces Positive Results from STIMULUS Trial: Diaphragm Neurostimulation Improves Hemodynamic Performance During Mechanical Ventilation
February 20, 2025
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Medical Announces Premarket Approval for AeroPace® System
December 05, 2024
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Lungpacer Medical Announces PMA Submission for AeroPace® System
September 04, 2024
From
Lungpacer Medical USA Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.